"Impotence, Vasculogenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inability to achieve and maintain an erection (ERECTILE DYSFUNCTION) due to defects in the arterial blood flow to the PENIS, defect in venous occlusive function allowing blood drainage (leakage) from the erectile tissue (corpus cavernosum penis), or both.
- Impotence, Venogenic
- Venogenic Impotence
- Venous Leakage, Penile
- Leakage, Penile Venous
- Penile Venous Leakage
Below are MeSH descriptors whose meaning is more general than "Impotence, Vasculogenic".
Below are MeSH descriptors whose meaning is more specific than "Impotence, Vasculogenic".
This graph shows the total number of publications written about "Impotence, Vasculogenic" by people in this website by year, and whether "Impotence, Vasculogenic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Impotence, Vasculogenic" by people in Profiles.
The cumulative effects of medication use, drug use, and smoking on erectile dysfunction among men who have sex with men. J Sex Med. 2012 Apr; 9(4):1106-13.
Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010 Nov; 7(11):3572-88.
Inflatable penile prosthesis placement in men with Peyronie's disease and drug-resistant erectile dysfunction: A single-center study. J Sex Med. 2010 Nov; 7(11):3775-83.
Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial. Arch Intern Med. 2004 Mar 08; 164(5):514-20.
Penile vascular assessment using color duplex sonography in men with Peyronie's disease. J Urol. 1996 Apr; 155(4):1270-3.
Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study. J Urol. 1995 Sep; 154(3):1017-9.